Physician profile
Thomas Darrell
NPI 1023003134
$4,987.69
in general payments reported to CMS, 2019-2025
41 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,364 · 2020: $512 · 2021: $495 · 2022: $754 · 2023: $739 · 2024: $629 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,861.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,481.53 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $1,068.78 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $422.98 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $323.44 | 2019-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $154.57 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.94 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $147.01 | 2019-2020 | |
| Glaxosmithkline, LLC. | $138.23 | 2020-2024 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $106.38 | 2019-2024 | Ubrelvy |
| Sanofi-Aventis U.S. LLC | $96.46 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $81.53 | 2020-2025 | Capvaxive, Gardasil 9, Gardasil |
| Exact Sciences Corporation | $66.30 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $63.33 | 2022-2024 | |
| Dexcom, INC. | $58.26 | 2024-2025 | Dexcom G6 Transmitter |
| Tolmar, INC. | $52.13 | 2024-2025 | Jatenzo |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Darrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.